Onconetix Inc. (ONCO)
ONCO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5550
-6.00% on the day
Market cap
$2.9M
Nano cap
Revenue · 2025
$815K
-67.7% on 2024
Net income · 2025
-$14.0M
-1721.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ONCO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001782107 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $815K |
| Net income | -$14.0M |
| Operating income | -$17.9M |
| Net margin | -1721.0% |
| Operating margin | -2190.0% |
| Revenue growth | -67.7% |
| Cash | Not in SEC XBRL data |
| Total assets | $24.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-09-08 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-13 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-13 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-14 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2026-10-07 |
Source: SEC EDGAR submissions feed, 389 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PRFX | PRF Technologies Ltd. | $0.8180 | -4.88% | $2.9M |
| DCOY | Decoy Therapeutics Inc. | $1.24 | -13.29% | $3.0M |
| MBIO | Mustang Bio Inc. | $0.3768 | -8.63% | $2.9M |
| HCWB | HCW Biologics Inc. | $1.26 | -14.87% | $2.8M |
| KAPA | Kairos Pharma Ltd. | $0.8287 | -0.40% | $2.8M |
| XRTX | XORTX Therapeutics Inc. Common Shares | $1.68 | -2.33% | $3.1M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
| RDHL | Redhill Biopharma Ltd. | $0.5150 | -3.45% | $3.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier